https://www.zonebourse.com/cours/action/NOVARTIS-AG-9364983/actualite/Novartis-renonce-a-demander-l-homologation-du-biosimilaire-de-Rituximab-aux-USA-27542827/?utm_source=telegram&utm_medium=social&utm_campaign=share